Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants.

CT, Collins; M, Makrides; AJ, McPhee; TR, Sullivan; PG, Davis; M, Thio; K, Simmer; VS, Rajadurai; J, Travadi; MJ, Berry; HG, Liley; GF, Opie; K, Tan; K, Lui; SA, Morris; J, Stack; MJ, Stark; MC, Chua; PA, Jayagobi; J, Holberton; S, Bolisetty; IR, Callander; DL, Harris; RA, Gibson

doi:10.1056/nejmoa1611942

Public

Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants.

Shared by NobleBlocks on Mar 1, 2017 • 12:00 AM UTC

Authors:

Collins CT

Makrides M

McPhee AJ

Abstract

Background Studies in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking.Methods We randomly assigned 1273 infants born before 29 weeks ...

Discussions